Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

United States Antimony (UAMY) EBT (2016 - 2025)

United States Antimony's EBT history spans 15 years, with the latest figure at -$4.7 million for Q3 2025.

  • For Q3 2025, EBT fell 1590.96% year-over-year to -$4.7 million; the TTM value through Sep 2025 reached -$4.9 million, down 17.18%, while the annual FY2024 figure was -$1.7 million, 72.87% up from the prior year.
  • EBT for Q3 2025 was -$4.7 million at United States Antimony, down from $336325.0 in the prior quarter.
  • Across five years, EBT topped out at $779580.0 in Q1 2022 and bottomed at -$4.7 million in Q3 2025.
  • The 5-year median for EBT is -$99232.0 (2021), against an average of -$564634.6.
  • The largest annual shift saw EBT crashed 3286.42% in 2024 before it soared 458.28% in 2025.
  • A 5-year view of EBT shows it stood at $37110.0 in 2021, then tumbled by 2962.21% to -$1.1 million in 2022, then crashed by 236.16% to -$3.6 million in 2023, then skyrocketed by 62.6% to -$1.3 million in 2024, then plummeted by 248.6% to -$4.7 million in 2025.
  • Per Business Quant, the three most recent readings for UAMY's EBT are -$4.7 million (Q3 2025), $336325.0 (Q2 2025), and $738680.0 (Q1 2025).